Respiratory & Infectious Diseases Codexery

Albendazole

Albendazole

It is used for the treatment of a variety of intestinal parasite infections, including ascariasis, pinworm infection, hookworm infection, trichuriasis, strongyloidiasis, taeniasis, clonorchiasis, opisthorchiasis, cutaneous larva migrans, giardiasis, and gnathostomiasis, among other diseases. It is on the World Health Organization's List of Essential Medicines and is available in a fixed-dose combination with ivermectin.

class
benzimidazole
type
broad-spectrum antihelmintic and antiprotozoal agent
common_side_effects
nausea, abdominal pain, headache
serious_side_effects
bone marrow suppression, liver inflammation
pregnancy_category
D in Australia
essential_medicines_list
World Health Organization

Lore & Background

It is effective against diseases such as cysticercosis, echinococcosis, ascariasis, hookworm infection, and giardiasis. The drug is often preferred in endemic countries due to its lower cost and broader spectrum compared to alternatives like praziquantel.

Reader's Guide

Albendazole is a key medication in global public health, listed on the World Health Organization's Essential Medicines List. Its significance lies in its broad-spectrum activity against intestinal parasites and tissue-dwelling helminths, making it a cornerstone of mass drug administration programs for neglected tropical diseases. Common side effects include headache and abnormal liver function, while rare but serious effects include bone marrow suppression and liver inflammation. The drug is contraindicated in those with hypersensitivity to benzimidazoles and is pregnancy category D in Australia.

Did You Know?

More in Respiratory & Infectious Diseases 1-24

Elsewhere in the Respiratory & Infectious Diseases universe

Spotted an error? Know more?

This is a living reference — every entry is fact-audited, and reader corrections feed straight into our audit queue. Suggest an edit · See this site's audit record

Comments

Loading…
Open in the interactive codex →